Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.66 USD | -0.75% | -3.78% | +70.51% |
01:15pm | Earnings Flash (RNLX) RENALYTIX Reports Q3 Revenue $535,000 | MT |
04-18 | Renalytix chief business officer to become president | AN |
Sales 2024 * | 4M 316M | Sales 2025 * | 18M 1.42B | Capitalization | 47.59M 3.76B |
---|---|---|---|---|---|
Net income 2024 * | -35M -2.77B | Net income 2025 * | -26M -2.06B | EV / Sales 2024 * | 11.9 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.64 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 64.33% |
Latest transcript on Renalytix Plc
1 week | -3.78% | ||
Current month | -4.03% | ||
1 month | -25.52% | ||
3 months | -45.04% | ||
6 months | +25.45% | ||
Current year | +70.51% |
Managers | Title | Age | Since |
---|---|---|---|
James McCullough
FOU | Founder | 56 | 14/03/18 |
James Sterling
DFI | Director of Finance/CFO | 54 | 14/03/18 |
Howard Doran
PSD | President | 63 | 31/08/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Levangie
BRD | Director/Board Member | 73 | 29/08/21 |
Chairman | 72 | 14/03/18 | |
James McCullough
FOU | Founder | 56 | 14/03/18 |
Date | Price | Change | Volume |
---|---|---|---|
14/05/24 | 0.665 | +7.41% | 118 621 |
13/05/24 | 0.6191 | +0.34% | 86,994 |
10/05/24 | 0.617 | -2.59% | 238,100 |
09/05/24 | 0.6334 | -1.19% | 180,198 |
08/05/24 | 0.641 | -7.25% | 216,592 |
Delayed Quote Nasdaq, May 14, 2024 at 09:00 pm
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.06% | 19.25B | |
-40.05% | 2.96B | |
+23.79% | 1.96B | |
+1.29% | 1.69B | |
+30.67% | 1.27B | |
-14.61% | 982M | |
-20.31% | 913M | |
+5.45% | 801M | |
-24.78% | 630M |
- Stock Market
- Equities
- RENX Stock
- RNLX Stock